Reed Wilcox

Samsonite LLC provides travel solutions. It designs and manufactures travel, luggage bags and accessories. The firm offers service and repair for its products. The company was founded in 1910 and is headquartered in Mansfield, MA.

General Resonance LLC provides resonance technology for healthcare and energy products. It focuses on products such as materials, energy and data storage. The firm also provides research and development, commercialization of patent discoveries related to resonance science and its potential applications. The company was founded by Juliana Brooks Mortenson and Reed N. Wilcox on April 9, 2004 and is headquartered in Havre de Grace, MD.

Corporation of The Presiding Bishop of The Church of Jesus Christ of Latter-Day Saints operates a church. It was founded on July 13, 1916 and is headquartered in Salt Lake City, UT.

The Boston Consulting Group, Inc. engages in the provision of management consulting services. It specializes in automotive and mobility; biopharmaceuticals; consumer products; education; oil and gas; power and utilities; engineered products and infrastructure; financial institutions; and health care payers, providers, and services. It offers big data and advanced analytics; change management; client learning and enablement; and corporate development and financial services. The company was founded by Bruce Doolin Henderson in 1963 and is headquartered in Boston, MA.

Part of Brown & Brown, Inc., The Flagship Group Ltd provides insurance services to marine operations and fishing vessels. The company is based in Norfolk, VA. The company was founded by Stephen A. Johnsen, Reed N. Wilcox. The Flagship Group was acquired by Brown & Brown, Inc. on November 22, 2000.

Clene Nanomedicine, Inc. is a clinical-stage biopharmaceutical company, which develops therapeutic candidates for neurodegenerative diseases. It focuses on the development of therapeutic nanocatalyst, CNM-Au8, for treatment of neurodegenerative diseases with a Phase 3 study underway in amyotrophic lateral sclerosis (ALS), and concurrent Phase 2 clinical programs ongoing for the neuroreparative treatment of multiple sclerosis, Parkinson's disease, and ALS. The company was founded by Reed N. Wilcox and Mark G. Mortenson in 2013 and and is headquartered in Salt Lake City, UT.